非结核性菌根性肺病的治疗需要逐步和多学科的方法
Arthur Lemson1, Arjan van Laarhoven2, Lisa Kurver2
1Department of Pulmonary Diseases, Research Institute for Medical Innovation, Radboud University Medical Center, Radboudumc Community for Infectious Diseases, Nijmegen, Netherlands.
Expert review of respiratory medicine
|March 21, 2025
概括
非结核性菌根性肺病 (NTM-PD) 治疗结果不佳,目前的指导方针提供了有限的改善. 这项研究提出了一种逐步的方法,以提高NTM-PD管理和患者的结果.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 医学真菌学 医学真菌学
背景情况:
- 非结核性菌根性肺病 (NTM-PD) 影响具有易感因素的个体.
- 目前对NTM-PD的治疗指南包括警等待,抗菌药物和手术干预.
- 对于NTM-PD的治疗成功率仍然不令人满意,有显著的培养转换和复发率.
研究的目的:
- 为NTM-PD提供一个全面的,逐步的治疗策略,以补充现有的指南.
- 为多学科评估,疾病严重程度分类和个性化护理提供建议.
- 通过整合临床专业知识和文献证据来改善NTM-PD管理.
主要方法:
- 在PubMed数据库的文献综述.
- 纳入来自专业参考诊所的临床专业知识.
- 逐步方法的开发,包括多学科评估,疾病分类和量身定制的疗法.
主要成果:
- 详细介绍了NTM-PD治疗的逐步方法.
- 建议涵盖多学科评估,疾病严重程度分类,个性化支持性护理,抗菌菌疗法,辅助手术和宿主导疗法.
- 拟议的战略旨在优化NTM-PD管理,超出目前的指导方针.
结论:
- 现有的NTM-PD治疗指南在实现令人满意的结果方面存在局限性.
- 一种结构化,逐步的方法,包括多学科的投入和个性化的护理,可以提高NTM-PD的管理.
- 为了充分执行这些建议,需要在不同的临床环境中进行进一步的研究和验证.
关键词:
药物不良反应 药物不良反应气道清除技术 气道清除技术克洛法齐米因 (Clofazimine) 是一种类药物.主体导向疗法 主体导向疗法过敏的盐水吸入过敏的盐水吸入这种药物是里法皮辛 (rifampicin).治疗药物监测 治疗药物监测更多相关视频
相关概念视频
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pneumonia IV: Management
282
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
282
Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214


